In addition, when we divided the NSCLC samples into two groups based on the PD-L1 expression level, we observed significantly higher CD8+ T cell and FOXP3+ Treg levels in the high PD-L1 expression group (Figures 2I, J). This evidence concerns the gene FOXP3 and non-small cell lung carcinoma.